Evidence map›Paper›PMID 41424670›Full record

ArticleHealth science reports2025

In-Hospital Death and Risk Factors in Adults With Respiratory Syncytial Virus in Spain (2016-2023). A Cross-Sectional Study With Focus on Older Patients.

Fatima Valero-Sempere, Mayarí Tortosa-González, Silvia Otero-Rodriguez, Maripaz Ventero, Juan Carlos Rodriguez-Diaz, Pilar Casasnovas, Hector Pinargote-Celorio, Rosario Sanchez-Martinez, Esperanza Merino, Jose Manuel Ramos-Rincon

Abstract read
In one paragraph

Article in Health science reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Fatima Valero-SempereInternal Medicine Department Dr. Balmis University General Hospital and Alicante Institute for Health and Biomedical Research (ISABIAL) Alicante Spain.ORCID https://orcid.org/0000-0002-0921-1854
Mayarí Tortosa-GonzálezInternal Medicine Department Dr. Balmis University General Hospital and Alicante Institute for Health and Biomedical Research (ISABIAL) Alicante Spain.
Silvia Otero-RodriguezInfectious Diseases Unit, Dr. Balmis University General Hospital and Alicante Institute for Health and Biomedical Research (ISABIAL) Alicante Spain.ORCID https://orcid.org/0000-0002-7801-5072
Maripaz VenteroMicrobiology Service, Dr. Balmis University General Hospital and Alicante Institute for Health and Biomedical Research (ISABIAL) Alicante Spain.ORCID https://orcid.org/0000-0003-1979-0949
Juan Carlos Rodriguez-DiazMicrobiology Service, Dr. Balmis University General Hospital and Alicante Institute for Health and Biomedical Research (ISABIAL) Alicante Spain.ORCID https://orcid.org/0000-0001-8007-5739
Pilar CasasnovasInternal Medicine Department Dr. Balmis University General Hospital and Alicante Institute for Health and Biomedical Research (ISABIAL) Alicante Spain.
Hector Pinargote-CelorioInfectious Diseases Unit, Dr. Balmis University General Hospital and Alicante Institute for Health and Biomedical Research (ISABIAL) Alicante Spain.ORCID https://orcid.org/0000-0002-3300-5807
Rosario Sanchez-MartinezInternal Medicine Department Dr. Balmis University General Hospital and Alicante Institute for Health and Biomedical Research (ISABIAL) Alicante Spain.
Esperanza MerinoInfectious Diseases Unit, Dr. Balmis University General Hospital and Alicante Institute for Health and Biomedical Research (ISABIAL) Alicante Spain.ORCID https://orcid.org/0000-0003-3854-4874
Jose Manuel Ramos-RinconInternal Medicine Department Dr. Balmis University General Hospital and Alicante Institute for Health and Biomedical Research (ISABIAL) Alicante Spain.ORCID https://orcid.org/0000-0002-6501-9867

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background and Aims: Respiratory syncytial virus (RSV) mortality varies across different populations. This study aims to assess RSV mortality in hospitalized adults (≥ 15 years) and identify key risk factors according to age. Methods: This was a retrospective, single-center study conducted in Alicante (Spain), including patients hospitalized for PCR-confirmed RSV infection between 2016 and 2023. Risk factors for death were assessed using multivariable logistic regression. Results: Of 367 patients admitted for RSV, 24 died (6.5%). Mortality was higher in very old adults (≥ 80 years, 8.9%) than in those aged under 80 years (4.8%). Significant risk factors were glomerular filtration rate (GFR) less than 38 mL/min/m Conclusion: RSV deaths increase with age. In-hospital mortality was associated with non-invasive mechanical ventilation and C-reactive protein levels and in patients under 80, and low GFR in older patients.

Indexed as

agedepidemicshospitalizationsintensive care unitlength of staymortalityover 80 and olderrespiratory syncytial virusRSVSpain

Identifiers

PMID41424670
PMCPMC12715264

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.